IMMUNITYBIO INC
IBRX·45256X103·US·Common Stock·Healthcare - Biotechnology-Activist
IBRX (IMMUNITYBIO INC) is held by 163 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($298.4M), STATE STREET CORP ($187.3M), VANGUARD PORTFOLIO MANAGEMENT LLC ($156.4M). Net institutional sentiment: Mixed. In Q2 2026, 1 member of Congress and 100 funds bought IBRX.
163
Holders
(13 Elite)
$1.6B
Total Value
61% (163)
Consensus
100 buying - 63 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 14, 2026 · Insiders Oct 6, 2026 · Activists Aug 6, 2026 · Congress Oct 12, 2026
InsiderSJSimon Barry J.Sell $269KOct 5, 2026
InsiderCCCohen CherylExercise 56K shOct 2, 2026
InsiderCCCohen CherylSell $851KOct 2, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 172
1 / 9
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer